TNL Mediagene has received a Nasdaq staff determination letter notifying the company that its securities are subject to delisting from the Nasdaq Capital Market. The determination cites a closing bid price below $1.00 per share for 30 consecutive business days from May 7, 2026 through June 18, 2026, and notes that a prior reverse stock split makes the company ineligible for a compliance period. An additional and separate basis for delisting is the previously notified non-compliance with the $2,500,000 minimum stockholders' equity requirement. The company intends to timely request a hearing before a Nasdaq Hearings Panel, which will automatically stay the suspension of trading and the filing of a Form 25-NSE pending the panel's decision. TNL Mediagene's ordinary shares will continue to trade under the symbol TNMG while the appeal is pending, though there is no assurance the panel will grant continued listing or that the company will regain compliance.
TNL Mediagene Ordinary SharesNasdaq delisting determination due to low bid price and non-compliance with stockholders' equity requirement.